Association of Insulin Treatment with Gastric Residue During an Esophagogastroduodenoscopy

Overview

Journal J Diabetes Investig

Specialty Endocrinology

Date 2021 Sep 9

PMID 34498411

Citations 2

Authors

Toshiko Kobori

Yukiko Onishi

Masahiko Iwamoto

Tetsuya Kubota

Takako Kikuchi

Tazu Tahara

Toshiko Takao

Hiroaki Fujiwara

Yoko Yoshida

Masato Kasuga

Affiliations

Soon will be listed here.

Abstract

The purpose of this study was to investigate the association of glycemic control and diabetes treatment to gastric residue observed during an esophagogastroduodenoscopy. Among 6,592 individuals who had esophagogastroduodenoscopy at our clinic between 2003 and 2019, we retrospectively and longitudinally identified those who had gastric residue during an esophagogastroduodenoscopy. Other data collected were age, sex, diagnosis of diabetes, glycated hemoglobin and diabetes medication. Cox proportional hazards models were used to assess the association of these data with the occurrence of gastric residue. To the best of our knowledge, this is the first retrospective cohort study finding that undergoing insulin treatment is a risk factor for gastric residue independent of age, sex and diabetes or glycated hemoglobin.

Citing Articles

Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy.

Kobori T, Onishi Y, Yoshida Y, Tahara T, Kikuchi T, Kubota T J Diabetes Investig. 2023; 14(6):767-773.

PMID: 36919944 PMC: 10204182. DOI: 10.1111/jdi.14005.

Association of insulin treatment with gastric residue during an esophagogastroduodenoscopy.

Kobori T, Onishi Y, Iwamoto M, Kubota T, Kikuchi T, Tahara T J Diabetes Investig. 2021; 13(3):501-504.

PMID: 34498411 PMC: 8902376. DOI: 10.1111/jdi.13665.

References

Kobori T, Onishi Y, Iwamoto M, Kubota T, Kikuchi T, Tahara T . Association of insulin treatment with gastric residue during an esophagogastroduodenoscopy. J Diabetes Investig. 2021; 13(3):501-504. PMC: 8902376. DOI: 10.1111/jdi.13665. View

Tesfaye S, Stevens L, Stephenson J, Fuller J, Plater M, Ionescu-Tirgoviste C . Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia. 1996; 39(11):1377-84. DOI: 10.1007/s001250050586. View

Serper M, Gawron A, Smith S, Pandit A, Dahlke A, Bojarski E . Patient factors that affect quality of colonoscopy preparation. Clin Gastroenterol Hepatol. 2013; 12(3):451-7. PMC: 3932336. DOI: 10.1016/j.cgh.2013.07.036. View

Kim Y, Seo E, Lee J, Lee S, Park H, Choi S . Inadequate Bowel Cleansing Efficacy of Split-dose Polyethylene Glycol for Colonoscopy in Type 2 Diabetic Patients: A Prospective and Blinded Study. J Clin Gastroenterol. 2016; 51(3):240-246. DOI: 10.1097/MCG.0000000000000536. View

Pop-Busui R, Boulton A, Feldman E, Bril V, Freeman R, Malik R . Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2016; 40(1):136-154. PMC: 6977405. DOI: 10.2337/dc16-2042. View

. Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing Elective Procedures: An Updated Report by the American Society of.... Anesthesiology. 2017; 126(3):376-393. DOI: 10.1097/ALN.0000000000001452. View

Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M . Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 1995; 333(2):89-94. DOI: 10.1056/NEJM199507133330203. View

Dik V, Moons L, Huyuk M, van der Schaar P, de Vos Tot Nederveen Cappel W, Ter Borg P . Predicting inadequate bowel preparation for colonoscopy in participants receiving split-dose bowel preparation: development and validation of a prediction score. Gastrointest Endosc. 2015; 81(3):665-72. DOI: 10.1016/j.gie.2014.09.066. View

Freemantle N, Balkau B, Home P . A propensity score matched comparison of different insulin regimens 1 year after beginning insulin in people with type 2 diabetes. Diabetes Obes Metab. 2013; 15(12):1120-7. PMC: 4237113. DOI: 10.1111/dom.12147. View

10.

Izzy M, Changela K, Alhankawi D, Haeri N, Shah S, Jibara G . Impact of glycemic control on colonoscopy outcomes: bowel preparation and polyp detection. Ann Gastroenterol. 2016; 29(3):332-5. PMC: 4923819. DOI: 10.20524/aog.2016.0060. View

11.

Kawamori R, Node K, Hanafusa T, Atsumi Y, Naito Y, Oka Y . Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter,.... Cardiovasc Diabetol. 2013; 12:131. PMC: 3846906. DOI: 10.1186/1475-2840-12-131. View

12.

Freemantle N, Balkau B, Danchin N, Wang E, Marre M, Vespasiani G . Factors influencing initial choice of insulin therapy in a large international non-interventional study of people with type 2 diabetes. Diabetes Obes Metab. 2012; 14(10):901-9. PMC: 3466417. DOI: 10.1111/j.1463-1326.2012.01613.x. View

13.

Taylor C, Schubert M . Decreased efficacy of polyethylene glycol lavage solution (golytely) in the preparation of diabetic patients for outpatient colonoscopy: a prospective and blinded study. Am J Gastroenterol. 2001; 96(3):710-4. DOI: 10.1111/j.1572-0241.2001.03610.x. View

14.

Hassan C, Fuccio L, Bruno M, Pagano N, Spada C, Carrara S . A predictive model identifies patients most likely to have inadequate bowel preparation for colonoscopy. Clin Gastroenterol Hepatol. 2012; 10(5):501-6. DOI: 10.1016/j.cgh.2011.12.037. View